Tage Honore

Insider Reports History

Location
Washington, DC
Signature
/s/ Tage Honore
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tage Honore:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. Director Common Stock 123,469 $487,702 $3.95 05 Jun 2025 Direct

Insider Reports Filed by Tage Honore

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VNDA Vanda Pharmaceuticals Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 17:34
VNDA Vanda Pharmaceuticals Inc. 17 May 2024 2 $0 4 Director 21 May 2024, 16:55
VNDA Vanda Pharmaceuticals Inc. 08 Jun 2023 2 $0 4 Director 12 Jun 2023, 16:19
VNDA Vanda Pharmaceuticals Inc. 15 Mar 2023 2 $0 4 Director 17 Mar 2023, 16:50
VNDA Vanda Pharmaceuticals Inc. 15 Mar 2023 0 $0 3 Director 17 Mar 2023, 16:49